According to the U.S. regulations, any medical institution that wishes to be involved in any clinical study funded by the U.S. federal government or any U.S. governmental agencies (e.g. the U.S. National Institutes of Health (NIH)) must use institutional review boards/research ethics committees (IRBs/RECs) registered with the U.S. Office for Human Research Protections (OHRP) for review and oversight of its clinical studies.
To facilitate collaboration in international clinical research, HKU/HA HKW IRB has registered with the OHRP. Each of HKU and HA HKW has also filed a Federalwide Assurance (FWA) with the OHRP to acknowledge its reliance on HKU/HA HKW IRB on ethics and scientific oversight of clinical studies.
|Assurance Name||OHRP Assurance No.|
|The University of Hong Kong/Hospital Authority Hong Kong West Cluster (HKU/HA HKW IRB)||IRB00005123|
|The University of Hong Kong (HKU)||FWA00019097|
|Hospital Authority Hong Kong West Cluster (HA HKW)||FWA00009362|